Mutations in the TMEM106B gene significantly increases a person’s risk of frontotemporal lobar degeneration (FTLD), the second most common cause of dementia in those under 65, researchers have demonstrated. While the data confirmed the gene’s clinical relevance, it didn’t tell researchers how it caused the disease — which is vital to developing new therapeutics.